1α,25-Dihydroxyvitamin D3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death

Endocrinology

Volumn 140, Issue 4, 1999, Pages 1649-1656

  Wang, Su He ^a   Koenig, Ronald J ^a   Giordano, Thomas J ^a   Myc, Andrzej ^a   Thompson, Norman W ^a   Baker Jr , James R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PROTEIN BCL 2; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL X; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL PROTECTION; GENE EXPRESSION REGULATION; HASHIMOTO DISEASE; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CELL; BREAST TUMOR; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; KINETICS; METABOLISM; PROTO ONCOGENE; THYROID GLAND; ULTRAVIOLET RADIATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BREAST NEOPLASMS; CALCITRIOL; GENE EXPRESSION REGULATION; GENES, BCL-2; HUMANS; KINETICS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; STAUROSPORINE; THYROID GLAND; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 0032586710     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.4.6659     Document Type: Article

References (34)

1. 1. Kloos RT, Baker Jr JR 1996 Thyroiditis. In: Robert ER (ed) Conn's Current Therapy. WB Saunders Company, Philadelphia, pp 634-641
2. 2. Arscott PL, Knapp J, Rymaszewski M, Bartron JL, Bretz JD, Thompson NW, Baker Jr JR 1997 Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor. Endocrinology 138:5019-5027
3. 3. Giordano C, Stassi G, De-Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A 1997 Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963
4. 4. Kotani T, Aratake Y, Hirai K, Fukazawa Y, Sato H, Ohtaki S 1995 Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity 20:231-236
5. 5. Kawakami AK, Eguchi K, Matsuoka N, Tsubio M, Kawabe Y, Ishikawa N, Ito K, Nagataki S 1996 Thyroid-stimulating hormone inhibits fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 137:3163-3169
6. 6. White E 1996 Life, death, and the pursuit of apoptosis. Genes Dev 10:1-15
7. 7. Oltvai ZN, Milliman CL, Korsmeyer SL 1993 Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619
8. 8 Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer SJ 1991 Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965
9. 9. Branet F, Brousset P, Krajewski S, Schlaifer D, Selves J, Reed JC, Caron P 1996 Expression of the cell death-induced gene bax in carcinomas developed from the follicular cells of the thyroid grand. J Clin Endocrinol Metab 81:2726-2730
10. 10. Manolagas SC, Hustmyer F, Yu XP 1989 1α,25-dihydroxyvitamin D3 and the immune system. Proc Soc Exp Biol Med 191:238-245
11. 11. Bouillon R, Okamura W, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257
12. 12 Baker AR, McDonnell DP, Hughes M, Crip TM, Mangelsdorf DJ, Haussler MR 1988 Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294-3298
13. 13 Norman AW, Nemere I, Zhou L, Bishop JE, Lowe KE, Maiyar AC, Collins ED, Taoka T, Sergeev I, Farach-Carson MC 1992 1,25(OH)2-vitamin D3, a steroid hormone that produced biologic effects via both genomic and non-genomic pathways. J Steroid Biochem Mol Biol 41:231-240
14. 14. James SY, Mackay AG, Colston KW 1996 Effects of 1,25-dihydroxyvitamin D3 and its analogs on induction of apoptosis in breast cancer cells. J Steroid Biochem Mol Biol 58:395-401
15. 15. Fournier C, Gepner P, Sadouk M, Charreire J 1990 In vivo beneficial effects of cyclosporine A and 1α,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 54:53-63
16. 16 Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM 1997 Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem 41:25783-25786
17. 17. Baker Jr JR 1997 Autoimmune endocrine diseases. JAMA 278:1931-1937
18. 18. Okayasu I, Saegusa M, Fujiwara M, Hara Y, Rose NR 1995 Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma. J Cancer Res Clin Oncol 121:746-752
19. 19 Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N, Ota Z 1995 Apoptosis in thyroid diseases: a histochemical study. Endocr J 42:193-201
20. 20. Mandal M, Maggirwar SB, Sharma N, Kaufmann SH, Sun S, Kumar R 1996 Bcl-2 prevent CD95 (Fas/APO-1)-induced degradation of lamin B and poly (ADP-ribose) polymerase and restores the NF-kB signaling pathway. J Biol Chem 271:30354-30359
21. 21. Rose LM, Latchman DS, Isenberg DA 1994 Bcl-2 and Fas molecules which influence apoptosis. A possible role in systemic lupus erythematosus. Auto-immunity 17:271-278
22. 22. Norman AW, Okamura WH, Hammond MW, Bishop JE, Dormanen MC, Bouillon R, Baelen HV, Ridall AL, Daane E, Khoury R, Farach-Carson MC 1997 Comparison of 6-s-cis-and 6-s-trans-locked analogs of 1α,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis nor 6-s-trans-locked analogs are preferred for genomic biological responses. Mol Endocrinol 11:1518-1531
23. 23. Tokuda N, Mano T, Levy RB 1990 1α,25-dihydroxyvitamin D3 antagonizes interferon-γ-induced expression of class II major histocompatibility antigens on thyroid follicular and testicular levdig cells. Endocrinology 127:1419-1427
24. 24. Pehn JL, Pagan DL, Jordan SC, Adams JS 1992 Potentiation of lipopolysaccharide-induced tumor necrosis factor-α expression by 1α,25-dihydroxyvitamin D3. Blood 80:2811-2816
25. 25. Taimi M, Defacque H, Commes T, Favero J, Caron E, Marti J, Dornand J 1993 Effect of retinoic acid and vitamin D on the expression of interleukin-1β, tumor necrosis factor-α and interleukin-6 in the human monocytic cell line U937. Immunology 79:229-235
26. 26. Hannah SS, Norman AW 1994 1α,25-dihydroxyvitamin D3-regulated expression of the eukaryotic genome. Nutr Rev 52:376-382
27. 27. Kuno H, Kurian SM, Hendy GY, White J, DeLuca HF, Evans C, Nanes MS 1994 Inhibition od 1α,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-α: structural determinants with the vitamin D response element. Endocrinology 134:2524-2531
28. 28. Kerry DM, Dwivedi PP, Nahn CN, Morris HA, Omdahl JL, May BK 1996 Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter. J Biol Chem 271:29715-29721
29. 29. Freedman LP, Arce V, Fernandez RP 1994 DNA sequences that act as high affinity targets for vitamin D3 receptor in the absence of the retinoid X receptor. Mol Endocrinol 8:265-273
30. 30. Adachi M, Tsujimoto Y 1990 Potential Z-DNA element surround the breakpoints of chromosome translocation within the 5′ flanking region of Bcl-2 gene. Oncogene 5:1653-1657
31. 31. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
32. 32. Okazawa H, Shimizu J, Kamei M, Imafuku I, Hamada H, Kanazawa I 1996 Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J Cell Biol 132:955-968
33. 33. Kyprianou N, King ED, Bradbury D, Rhee JG 1997 Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J Cell Biol 132:955-968
34. 34. Zhou JY, Norman AW, Lubert M, Collins ED, Uskokovic MR, Koeffler HP 1989 Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect of either intestinal calcium absorption or bone calcium mobilization. Blood 74:82-93